CCA
CMD

Catalyst Capital Advisors’s Cantel Medical Corporation CMD Stock Holding History

Catalyst Capital Advisors’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,500
Closed -$279K – 581
2018
Q1 		$279K Buy
+2,500
New +$280K 0.01% 231

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Catalyst Capital Advisors's CMD Position: Q2 2018 in Review

Catalyst Capital Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2018, closing a stake of 2,500 shares — an estimated $279K sold.

Catalyst Capital Advisors first reported a position in CMD in Q1 2018 and held it in 1 quarter. The position peaked at $279K in Q1 2018. 292 funds tracked by Wall St. Rank hold CMD as of Q2 2018.

  • Catalyst Capital Advisors reported no remaining Cantel Medical Corporation position as of Q2 2018 after selling out during the quarter.
  • Catalyst Capital Advisors sold 2,500 Cantel Medical Corporation shares in Q2 2018, an estimated $279K.
  • Catalyst Capital Advisors first reported a position in Cantel Medical Corporation in Q1 2018 and held it in 1 quarter.
  • Catalyst Capital Advisors's Cantel Medical Corporation position peaked at $279K in Q1 2018.
  • 292 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2018.

Based on Catalyst Capital Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.